PUBLISHER: DelveInsight | PRODUCT CODE: 1047583
PUBLISHER: DelveInsight | PRODUCT CODE: 1047583
DelveInsight's, "Vascular Grafts -Pipeline Insight and 2022," report provides comprehensive insights about 20+ companies and 25+ pipeline devices in Vascular Grafts pipeline landscape. Heart disease has been the world's biggest cause of mortality, with this trend forecast to continue into the near future. Common disorders contribute to blood vessel stenosis or occlusion. Surgeries using vascular grafts such as coronary artery bypass grafting and peripheral artery bypass grafting is the recommended treatment for long-term revascularization of occluded vessels. Over the past forty years, significant progress has been made in our perception of successful regeneration of the blood vessels, beginning with the inadequacies of early tissue-engineered vascular grafts engineered using isolated components or molecules, such as collagen gels. In the coming years, all these advancements will eventually lead to growth in the market.
Vascular Grafts Overview
Vascular Grafts: Understanding
A vascular graft (also called vascular bypass) is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting the blood vessels. Vascular grafting is most commonly done to bypass a complete or partial blockage in an artery in order to improve blood flow to the organ or extremity supplied by the diseased artery. Vascular grafts are of different types based on the indication and raw materials used for the graft to suit the host tissue.
Vascular Grafts Devices Competitive Assessment
This segment of the vascular grafts devices pipeline report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including the latest news and press releases. The report also provides list of major players involved in the pipeline product development.
Vascular Grafts can be divided based on raw materials - Polyester Grafts, ePTFE, Polyurethane Grafts and Biosynthetic Grafts, which are covered in the report.
Vascular Grafts can be divided based on its application - Cardiac Aneurysms, Vascular Occlusion and Kidney Failure, which are covered in the report.
There are approx. 20+ key companies which are developing the products for Vascular Grafts.
NuSpun Vascular Graft is being developed by BioSurfaces which has completed initial preclinical trials. It has following features:
RegenaVasc, developed by RegenaGraft is synthetic vascular repair and replacement for vascular (artery and vein) applications.
Further product details are provided in the report……..
Vascular Grafts Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.
The analysis is based on
Vascular Grafts: Commercialization Activity
This segment of the report provides a detailed list of any commercial activity in the field of vascular grafts ranging from collaboration, mergers and acquisition, recent breakthrough among others.
Development Activities
Further commercial activities are provided in the report……..
Vascular Grafts: Reimbursement
The special control for this device is the FDA guidance document entitled "Guidance Document for Vascular Prostheses 510(k) Submissions" under CFR - Code of Federal Regulations Title 21.
Further information is provided in the report……..
Key Questions
Key Players